Evidence map›Paper›PMID 41517497›Full record

ArticleJournal of clinical medicine2025

Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer.

Ezgi Turkoglu, Nisanur Sarıyar Busery, Sedat Yildirim, Goncagül Akdağ Topal, Cevher Burcu Salman, Erhan Conay, Furkan Turkoglu, Ozhan Albayrak, Seval Ay Ersoy, Deniz Isik and 3 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ezgi TurkogluDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.ORCID 0000-0003-3846-7047
Nisanur Sarıyar BuseryDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.
Sedat YildirimDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.
Goncagül Akdağ TopalDepartment of Medical Oncology, Tokat State Hospital, 60100 Tokat, Türkiye.
Cevher Burcu SalmanDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.
Erhan ConayDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.
Furkan TurkogluDepartment of General Surgery, Aktif International Hospital, 41275 Kocaeli, Türkiye.ORCID 0000-0002-5942-1518
Ozhan AlbayrakDepartment of General Surgery, Yozgat City Hospital, 66100 Yozgat, Türkiye.
Seval Ay ErsoyDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.ORCID 0000-0002-7555-2657
Deniz IsikDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.
Hatice OdabaşDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.
Cihad TatarIndependent Researcher, Canberra, ACT 2605, Australia.
Nedim TuranDepartment of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, 34865 İstanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant chemotherapycolon cancerprognosisrecurrence-free survivalT3N1 stagetumor size

Identifiers

PMID41517497
PMCPMC12786785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.